Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients

Table 3

Adverse effects seen in more than 5% of the cases in the first month of treatment.

	$N$	%
Fatty stool	55	47.1
Increased defecation	22	18.5
Dry mouth	13	10.,9
Diarrhea	13	10.9
Oily drops	12	10.1
Flatus with discharge	11	9.2
Increased appetite	10	8.4
Constipation	8	6.7
Fecal urgency	7	5.9

$N$ = Number of individuals who reported adverse effects.